151. Study on network pharmacology of Ginkgo biloba extract against ischaemic stroke mechanism and establishment of UPLC‐MS/MS methods for simultaneous determination of 19 main active components.
- Author
-
Yin, Chun‐Yan, Lian, Yuan‐Pei, Xu, Jian‐Da, Liu, Chan‐Ming, Cai, Jia‐Li, Zhu, Li, Wang, Di‐Jun, Luo, Li‐Bo, and Yan, Xiao‐Jing
- Abstract
Introduction: Ginkgo biloba extract (GBE) is an effective substance from traditional Chinese medicine (TCM) G. biloba for treating ischaemic stroke (IS). However, its active ingredients and mechanism of action remain unclear. Objectives: This study aimed to reveal the potential active component group and possible anti‐IS mechanism of GBE. Materials and methods: The network pharmacology method was used to reveal the possible anti‐IS mechanism of these active ingredients in GBE. An ultra‐high‐performance liquid chromatography triple quadrupole electrospray tandem mass spectrometry (UPLC‐MS/MS) method was established for the simultaneous detection of the active ingredients of GBE. Results: The active components of GBE anti‐IS were screened by literature integration. Network pharmacology results showed that the anti‐IS effect of GBE is achieved through key active components such as protocatechuic acid, bilobalide, ginkgolide A, and so on. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the possible anti‐IS mechanism of GBE is regulating the PI3K‐Akt signalling pathway and other signal pathways closely related to inflammatory response and apoptosis regulation combined with AKT1, MAPK, TNF, ALB, CASP3, and other protein targets. Nineteen main constituents in seven batches of GBE were successfully analysed using the established UPLC‐MS/MS method, and the results showed that the content of protocatechuic acid, gallic acid, ginkgolide A, and so forth was relatively high, which was consistent with network pharmacology results, indicating that these ingredients may be the key active anti‐IS ingredients of GBE. Conclusion: This study revealed the key active components and the anti‐IS mechanism of GBE. It also provided a simple and sensitive method for the quality control of related preparations. In this study, a multi‐component determination method for the active ingredients was established, and the differences of active ingredients content in GBE was uncovered. Moreover, the possible key components of GBE anti‐IS were identified by content analysis and network pharmacology. The feasibility of GBE for the treatment of IS was confirmed from an anti‐inflammatory perspective and the key role of regulated lipid and atherosclerosis, PI3K‐Akt signaling pathway, and pathways of neurodegeneration. This study provides new strategy into mechanisms of GBE anti‐IS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF